Startup Dossier
Sonomind
Paris-based medtech developing a non-invasive, ultrasound-based neuromodulation device that precisely targets deep brain regions to treat psychiatric and neurological disorders, starting with drug-resistant depression.
active
Typestartup
SectorHealthTech
LocationParis
About
Paris-based medtech developing a non-invasive, ultrasound-based neuromodulation device that precisely targets deep brain regions to treat psychiatric and neurological disorders, starting with drug-resistant depression.
Structural DNA
Legal Name
Sonomind
SIREN
929049187
Founders & Team
Funding Lineage
Seed
Critical Path Ventures (Lead)
€3.0M
Sept 2025
Programs
i-Lab
2025Technologies médicales